BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16491981)

  • 1. Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine.
    Shen J; Chung SA; Kayumov L; Moller H; Hossain N; Wang X; Deb P; Sun F; Huang X; Novak M; Appleton D; Shapiro CM
    Can J Psychiatry; 2006 Jan; 51(1):27-34. PubMed ID: 16491981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
    Winokur A; DeMartinis NA; McNally DP; Gary EM; Cormier JL; Gary KA
    J Clin Psychiatry; 2003 Oct; 64(10):1224-9. PubMed ID: 14658972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study.
    Winokur A; Sateia MJ; Hayes JB; Bayles-Dazet W; MacDonald MM; Gary KA
    Biol Psychiatry; 2000 Jul; 48(1):75-8. PubMed ID: 10913511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.
    Kim SW; Shin IS; Kim JM; Kim YC; Kim KS; Kim KM; Yang SJ; Yoon JS
    Psychiatry Clin Neurosci; 2008 Feb; 62(1):75-83. PubMed ID: 18289144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mirtazapine on sleep polygraphic variables in major depression.
    Schittecatte M; Dumont F; Machowski R; Cornil C; Lavergne F; Wilmotte J
    Neuropsychobiology; 2002; 46(4):197-201. PubMed ID: 12566938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world, open-label study to evaluate the effectiveness of mirtazapine on sleep quality in outpatients with major depressive disorder.
    Wang D; Li Z; Li L; Hao W
    Asia Pac Psychiatry; 2014 Jun; 6(2):152-60. PubMed ID: 23857869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute psychosis associated with dissociated sleep-wakefulness state after mirtazapine treatment.
    Felthous AR; Wenger PJ; Hoevet R
    Pharmacotherapy; 2010 Apr; 30(4):145e-50e. PubMed ID: 20334466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
    CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mirtazapine in the treatment of adolescents with major depression: an open-label, multicenter pilot study.
    Haapasalo-Pesu KM; Vuola T; Lahelma L; Marttunen M
    J Child Adolesc Psychopharmacol; 2004; 14(2):175-84. PubMed ID: 15319015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
    Kim JE; Yoon SJ; Kim J; Jung JY; Jeong HS; Cho HB; Shin E; Lyoo IK; Kim TS
    Int J Clin Pract; 2011 Mar; 65(3):323-9. PubMed ID: 21314870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.
    Varia I; Venkataraman S; Hellegers C; Gersing K; Doraiswamy PM
    Psychopharmacol Bull; 2007; 40(1):47-56. PubMed ID: 17285095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment issues related to sleep and depression.
    Thase ME
    J Clin Psychiatry; 2000; 61 Suppl 11():46-50. PubMed ID: 10926055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of mirtazapine on urinary free cortisol excretion in depressed patients.
    Schule C; Baghai T; Rackwitz C; Laakmann G
    Psychiatry Res; 2003 Oct; 120(3):257-64. PubMed ID: 14561437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
    Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
    World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mirtazapine--pharmacologic action and clinical advantages].
    Rihmer Z; Purebl G
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):35-40. PubMed ID: 19731817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
    Fava M; Rush AJ; Wisniewski SR; Nierenberg AA; Alpert JE; McGrath PJ; Thase ME; Warden D; Biggs M; Luther JF; Niederehe G; Ritz L; Trivedi MH
    Am J Psychiatry; 2006 Jul; 163(7):1161-72. PubMed ID: 16816220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirtazapine-induced manic switch in adolescent unipolar depression.
    Goyal N; Sinha VK
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1070-1. PubMed ID: 19031640
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of mirtazapine on sleep in patients with major depressive disorder.
    Dolder CR; Nelson MH; Iler CA
    Ann Clin Psychiatry; 2012 Aug; 24(3):215-24. PubMed ID: 22860241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mirtazapine versus fluoxetine on "sleep quality".
    Lawrence RW
    J Clin Psychiatry; 2004 Aug; 65(8):1149-50. PubMed ID: 15323610
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential effects of trimipramine and fluoxetine on sleep in geriatric depression.
    Wolf R; Dykierek P; Gattaz WF; Maras A; Kohnen R; Dittmann RW; Geuppert M; Riemann D; Berger M
    Pharmacopsychiatry; 2001 Mar; 34(2):60-5. PubMed ID: 11302565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.